Patents by Inventor ROBYN A.A. OLDHAM

ROBYN A.A. OLDHAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEM AND METHOD FOR THE DEVELOPMENT OF CD30 BISPECIFIC ANTIBODIES FOR IMMUNOTHERAPY OF CD30+ MALIGNANCIES
    Publication number: 20230312738
    Abstract: The present invention provides novel bispecific antibodies that bind to human CD30 and uses thereof. Methods of treating cancer using the bispecific antibodies described herein are also provided.
    Type: Application
    Filed: April 17, 2023
    Publication date: October 5, 2023
    Inventors: Jeffrey A. Medin, Lawrence G. Lum, Robyn A.A. Oldham, Archana Thakur
  • Multiple Myeloma Mapping and Uses Thereof
    Publication number: 20230280344
    Abstract: The present invention provides methods and kits for detecting and treating multiple myeloma. The methods involve detecting proteins that the inventors have identified as biomarkers of multiple melanoma.
    Type: Application
    Filed: July 15, 2021
    Publication date: September 7, 2023
    Inventors: Jeffrey A. Medin, Robyn A. Oldham, Mary L. Faber, Rebekah L. Gundry
  • Anti-CD30 Antibodies and Methods for Treating CD30+ Cancer
    Publication number: 20230235071
    Abstract: The present invention provides novel antibodies and antigen binding fragments thereof that bind to human CD30. Also presented are single chain variable antibodies, chimeric antigen receptors and uses thereof. Methods of treating cancer are also disclosed.
    Type: Application
    Filed: February 2, 2023
    Publication date: July 27, 2023
    Inventors: Jeffrey A. Medin, Mary L. Faber, Everett R. Tate, Robyn A.A. Oldham
  • CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies
    Patent number: 11667721
    Abstract: The present invention provides novel bispecific antibodies that bind to human CD30 and uses thereof. Methods of treating cancer using the bispecific antibodies described herein are also provided.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: June 6, 2023
    Assignees: Medical College of Wisconsin, Inc., University of Virginia Patent Foundation
    Inventors: Jeffrey A. Medin, Lawrence G. Lum, Robyn A. A. Oldham, Archana Thakur
  • Anti-CD30 antibodies and methods for treating CD30+ cancer
    Patent number: 11584799
    Abstract: The present invention provides novel antibodies and antigen binding fragments thereof that bind to human CD30. Also presented are single chain variable antibodies, chimeric antigen receptors and uses thereof. Methods of treating cancer are also disclosed.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: February 21, 2023
    Assignees: Medical College of Wisconsin, Inc., University of Virginia Patent Foundation
    Inventors: Jeffrey A. Medin, Mary L. Faber, Everett R. Tate, Robyn A. A. Oldham
  • T-Rapa Cells as Novel Effector Cell Type for Chimeric Antigen Receptor Therapy
    Publication number: 20220016167
    Abstract: The present disclosure provides chimeric antigen receptor (CAR)-T-Rapa cells and methods of making and using them. Specifically, methods of producing T-Rapa cells that can express chimeric antigen receptors is provided.
    Type: Application
    Filed: November 27, 2019
    Publication date: January 20, 2022
    Inventors: Jeffrey A. Medin, Robyn A. Oldham, Daniel H. Fowler, Tania Felizardo
  • SYSTEM AND METHOD FOR THE DEVELOPMENT OF CD30 BISPECIFIC ANTIBODIES FOR IMMUNOTHERAPY OF CD30+ MALIGNANCIES
    Publication number: 20200095330
    Abstract: The present invention provides novel bispecific antibodies that bind to human CD30 and uses thereof. Methods of treating cancer using the bispecific antibodies described herein are also provided.
    Type: Application
    Filed: September 24, 2019
    Publication date: March 26, 2020
    Inventors: Jeffrey A. Medin, Lawrence G. Lum, Robyn A.A. Oldham, Archana Thakur
  • ANTI-CD30 ANTIBODIES AND METHODS OF USE
    Publication number: 20200095329
    Abstract: The present invention provides novel antibodies and antigen binding fragments thereof that bind to human CD30. Also presented are single chain variable antibodies, chimeric antigen receptors and uses thereof. Methods of treating cancer are also disclosed.
    Type: Application
    Filed: September 24, 2019
    Publication date: March 26, 2020
    Inventors: JEFFREY A. MEDIN, MARY L. FABER, EVERETT R. TATE, ROBYN A.A. OLDHAM